<p>OPKO Health（纳斯达克代码：OPK - 获取免费报告）预计将在 2 月 27 日星期四市场收盘后发布季度财报。分析师预计 OPKO Health 每股收益为（$0.08），季度收入为 1.5542 亿美元。对参与公司电话会议感兴趣的投资者可以使用此链接。</p>
<h2>OPKO Health 股价上涨 2.4%</h2>
<ul>
<li>华尔街内部人士无法停止购买的 3 只股票</li>
</ul>
<p>OPKO Health 的股票在周二开盘价为 1.72 美元。OPKO Health 的 12 个月低点为 0.86 美元，12 个月高点为 1.76 美元。该公司的市值为 11.7 亿美元，市盈率为-9.05，贝塔系数为 1.63。公司的流动比率为 2.97，速动比率为 2.69，债务股本比率为 0.30。公司的 50 日移动平均价格为 1.54 美元，200 日移动平均价格为 1.55 美元。</p>
<h2>华尔街分析师预测增长</h2>
<p>一些股票研究分析师最近对 OPK 股票发布了报告。HC Wainwright 在 1 月 8 日星期三的报告中重申了 “买入” 评级，并对 OPKO Health 的股票设定了 3.00 美元的目标价。Barrington Research 在 11 月 8 日星期五的报告中重申了 “跑赢大盘” 评级，并对 OPKO Health 的股票设定了 2.25 美元的目标价。最后，StockNews.com 在 1 月 15 日星期三的报告中将 OPKO Health 的股票评级从 “持有” 下调至 “卖出”。</p>
<ul>
<li>MarketBeat 周回顾 – 7/17 - 7/21</li>
</ul>
<p><strong>查看我们关于 OPKO Health 的最新报告</strong></p>
<h2>OPKO Health 内部活动</h2>
<p>在相关消息中，首席执行官 Phillip Md Et Al Frost 在 11 月 29 日星期五的交易中购买了 199,072 股该股票。这些股票的平均成本为每股 1.53 美元，总价值为 304,580.16 美元。购买完成后，首席执行官现在直接拥有 211,911,477 股公司股票，价值 324,224,559.81 美元。这笔交易代表了其持股比例的 0.09% 的增加。此次收购在向 SEC 提交的文件中披露，文件可通过此超链接获取。内部人士在过去三个月购买了价值 2,313,710 美元的 1,521,609 股公司股票。47.26% 的股票由公司内部人士持有。</p>
<h2>OPKO Health 公司简介</h2>
<p>（获取免费报告）</p>
<ul>
<li>OPKO Health 是多元化医疗保健的小巨人</li>
</ul>
<p>OPKO Health, Inc 是一家医疗保健公司，在美国、爱尔兰、智利、西班牙、以色列、墨西哥及国际上从事诊断和制药业务。公司的诊断部门运营 BioReference Laboratories，提供实验室检测服务，用于疾病的检测、诊断、评估、监测和治疗，包括特殊检测、分子诊断、解剖病理学、遗传学、女性健康和监狱医疗保健，服务对象包括医生办公室、诊所、医院、雇主和政府单位；以及 4Kscore 前列腺癌检测。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票比 OPKO Health 更好</li>
<li>如何开始投资房地产</li>
<li>寻找隐藏的宝石：非常规的便士股票投资</li>
<li>投资中的下调意味着什么？</li>
<li>NVIDIA 的目标价在财报前上涨</li>
<li>现在要买的 2 只金融科技股票和 1 只要避免的股票</li>
<li>Archer Aviation 股票下滑：将进展误认为坏消息？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BL?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BL"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 OPKO Health 吗？</h2>
<p>在考虑 OPKO Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 OPKO Health 并不在名单上。</p>
<p>虽然 OPKO Health 目前在分析师中获得了 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OPKO保健

<p>OPKO 保健（NASDAQ:OPK）将于 2 月 27 日发布季度财报，分析师预测每股收益为（$0.08），收入为 1.5542 亿美元。该股票目前交易价格为$1.72，12 个月的价格区间为$0.86 至$1.76。最近的分析师评级包括 HC Wainwright 给予的 “买入” 评级，目标价为$3.00，以及 StockNews.com 的 “卖出” 下调评级。首席执行官 Phillip Frost 最近购买了 199,072 股，内部持股比例增加至 47.26%</p>

<p>OPKO Health (NASDAQ:OPK - Get Free Report) is anticipated to post its quarterly earnings results after the market closes on Thursday, February 27th. Analysts expect OPKO Health to post earnings of ($0.08) per share and revenue of $155.42 million for the quarter. Investors interested in participating in the company's conference call can do so using this link.</p>
<div class="lb-trans"><p>OPKO Health（纳斯达克代码：OPK - 获取免费报告）预计将在 2 月 27 日星期四市场收盘后发布季度财报。分析师预计 OPKO Health 每股收益为（$0.08），季度收入为 1.5542 亿美元。对参与公司电话会议感兴趣的投资者可以使用此链接。</p>
</div><h2>OPKO Health Trading Up 2.4 %</h2>
<div class="lb-trans"><h2>OPKO Health 股价上涨 2.4%</h2>
</div><ul>
<li>3 Stocks That Wall Street Insiders Can’t Stop Buying</li>
</ul>
<div class="lb-trans"><ul>
<li>华尔街内部人士无法停止购买的 3 只股票</li>
</ul>
</div><p>Shares of OPKO Health stock opened at $1.72 on Tuesday. OPKO Health has a 12-month low of $0.86 and a 12-month high of $1.76. The company has a market cap of $1.17 billion, a price-to-earnings ratio of -9.05 and a beta of 1.63. The company has a current ratio of 2.97, a quick ratio of 2.69 and a debt-to-equity ratio of 0.30. The company's 50-day moving average price is $1.54 and its 200-day moving average price is $1.55.</p>
<div class="lb-trans"><p>OPKO Health 的股票在周二开盘价为 1.72 美元。OPKO Health 的 12 个月低点为 0.86 美元，12 个月高点为 1.76 美元。该公司的市值为 11.7 亿美元，市盈率为-9.05，贝塔系数为 1.63。公司的流动比率为 2.97，速动比率为 2.69，债务股本比率为 0.30。公司的 50 日移动平均价格为 1.54 美元，200 日移动平均价格为 1.55 美元。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of equities research analysts have recently issued reports on OPK shares. HC Wainwright reissued a &#34;buy&#34; rating and issued a $3.00 price target on shares of OPKO Health in a report on Wednesday, January 8th. Barrington Research reissued an &#34;outperform&#34; rating and issued a $2.25 price target on shares of OPKO Health in a report on Friday, November 8th. Finally, StockNews.com downgraded shares of OPKO Health from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a report on Wednesday, January 15th.</p>
<div class="lb-trans"><p>一些股票研究分析师最近对 OPK 股票发布了报告。HC Wainwright 在 1 月 8 日星期三的报告中重申了 “买入” 评级，并对 OPKO Health 的股票设定了 3.00 美元的目标价。Barrington Research 在 11 月 8 日星期五的报告中重申了 “跑赢大盘” 评级，并对 OPKO Health 的股票设定了 2.25 美元的目标价。最后，StockNews.com 在 1 月 15 日星期三的报告中将 OPKO Health 的股票评级从 “持有” 下调至 “卖出”。</p>
</div><ul>
<li>MarketBeat Week in Review – 7/17 - 7/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 7/17 - 7/21</li>
</ul>
</div><p><strong>View Our Latest Report on OPKO Health</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 OPKO Health 的最新报告</strong></p>
</div><h2>Insider Activity at OPKO Health</h2>
<div class="lb-trans"><h2>OPKO Health 内部活动</h2>
</div><p>In related news, CEO Phillip Md Et Al Frost bought 199,072 shares of the stock in a transaction that occurred on Friday, November 29th. The shares were acquired at an average cost of $1.53 per share, with a total value of $304,580.16. Following the completion of the purchase, the chief executive officer now directly owns 211,911,477 shares of the company's stock, valued at $324,224,559.81. This trade represents a 0.09 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders have purchased 1,521,609 shares of company stock valued at $2,313,710 over the last three months. 47.26% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 Phillip Md Et Al Frost 在 11 月 29 日星期五的交易中购买了 199,072 股该股票。这些股票的平均成本为每股 1.53 美元，总价值为 304,580.16 美元。购买完成后，首席执行官现在直接拥有 211,911,477 股公司股票，价值 324,224,559.81 美元。这笔交易代表了其持股比例的 0.09% 的增加。此次收购在向 SEC 提交的文件中披露，文件可通过此超链接获取。内部人士在过去三个月购买了价值 2,313,710 美元的 1,521,609 股公司股票。47.26% 的股票由公司内部人士持有。</p>
</div><h2>OPKO Health Company Profile</h2>
<div class="lb-trans"><h2>OPKO Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><ul>
<li>OPKO Health is the Little Giant of Diversified Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>OPKO Health 是多元化医疗保健的小巨人</li>
</ul>
</div><p>OPKO Health, Inc, a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test.</p>
<div class="lb-trans"><p>OPKO Health, Inc 是一家医疗保健公司，在美国、爱尔兰、智利、西班牙、以色列、墨西哥及国际上从事诊断和制药业务。公司的诊断部门运营 BioReference Laboratories，提供实验室检测服务，用于疾病的检测、诊断、评估、监测和治疗，包括特殊检测、分子诊断、解剖病理学、遗传学、女性健康和监狱医疗保健，服务对象包括医生办公室、诊所、医院、雇主和政府单位；以及 4Kscore 前列腺癌检测。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than OPKO Health</li>
<li>How to Start Investing in Real Estate</li>
<li>Finding Hidden Gems: Unconventional Penny Stock Investing</li>
<li>What Does Downgrade Mean in Investing?</li>
<li>Price Targets on NVIDIA Rise in Front of Earnings</li>
<li>2 Fintech Stocks to Buy Now and 1 to Avoid</li>
<li>Archer Aviation Stock Skids: Mistaking Progress for Bad News?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 OPKO Health 更好</li>
<li>如何开始投资房地产</li>
<li>寻找隐藏的宝石：非常规的便士股票投资</li>
<li>投资中的下调意味着什么？</li>
<li>NVIDIA 的目标价在财报前上涨</li>
<li>现在要买的 2 只金融科技股票和 1 只要避免的股票</li>
<li>Archer Aviation 股票下滑：将进展误认为坏消息？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BL" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=OPK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in OPKO Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 OPKO Health 吗？</h2>
</div><p>Before you consider OPKO Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 OPKO Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OPKO Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 OPKO Health 并不在名单上。</p>
</div><p>While OPKO Health currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 OPKO Health 目前在分析师中获得了 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

OPKO 保健（OPK）将于周四公布财报